A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma (NEO-GLITIPNI).
- Dirven, I. (Speaker)
Activiteit: Talk or presentation at a conference
Activiteit: Talk or presentation at a conference